Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
5 drugs in development
By Therapeutic Area
top 3
R&D Momentum
56/100
Pipeline Velocity
19/100
Trial Completion Rate
92/100
Pipeline Concentration
33/100
Pipeline Freshness
0/100
Strategic Signals
Activity
Last 14 days
Phase 2b Clinical Trial Using Multiple Interventions With Distinct Anti-Reservoir Activities In People On Antiretroviral Treatment
Prospective Comparative Study of the Efficacy of Acupuncture Versus Conventional Treatment for the Management of Chronic Pain in Patients With Chronic Kidney Disease Receiving Conservative Treatment or Renal Replacement Therapy (Peritoneal Dialysis or Hemodialysis)
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)